Goldman Sachs
NURO

Goldman Sachs’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Goldman Sachs’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-185
Closed -$20K – 5780
2018
Q3 		$20K Buy
+185
New +$18.8K ﹤0.01% 5415
2017
Q3 		– Sell
-201
Closed -$43K – 6913
2017
Q2 		$43K Buy
+201
New +$62.4K ﹤0.01% 6391
2017
Q1 		– Sell
-40
Closed -$19K – 7063
2016
Q4 		$19K Buy
+40
New +$29.9K ﹤0.01% 6660
2015
Q1 		– Sell
-6
Closed -$31K – 7334
2014
Q4 		$31K Sell
6
-5
-45% -$21.9K ﹤0.01% 6922
2014
Q3 		$52K Buy
+11
New +$51.3K ﹤0.01% 6806

Other funds holding NURO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
Randolph Company Cincinnati, Ohio $1.19B AUM 38.92% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's NURO Position: Q4 2018 in Review

Goldman Sachs sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2018, closing a stake of 185 shares — an estimated $20K sold.

Goldman Sachs first reported a position in NURO in Q3 2014 and held it in 5 quarters. The position peaked at $52K in Q3 2014. 11 funds tracked by Wall St. Rank hold NURO as of Q4 2018.

  • Goldman Sachs reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Goldman Sachs sold 185 NeuroMetrix, Inc. Common Stock shares in Q4 2018, an estimated $20K.
  • Goldman Sachs first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
  • Goldman Sachs's NeuroMetrix, Inc. Common Stock position peaked at $52K in Q3 2014.
  • 11 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.